Denali Advisors LLC G1 Therapeutics, Inc. Transaction History

Denali Advisors LLC

  • $916 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024
SELL
$2.1 - $4.83 $74,970 - $172,431
-35,700 Reduced 29.31%
86,100 $371,000
Q4 2023

Jan 19, 2024
SELL
$1.12 - $3.73 $30,240 - $100,710
-27,000 Reduced 18.15%
121,800 $371,000
Q3 2023

Oct 19, 2023
BUY
$1.22 - $2.67 $99,674 - $218,139
81,700 Added 121.76%
148,800 $214,000
Q2 2023

Jul 18, 2023
BUY
$2.46 - $3.14 $165,066 - $210,694
67,100 New
67,100 $167,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email